Regulating for competition : government, law, and the pharmaceutical industry in the United Kingdom and France
Author(s)
Bibliographic Information
Regulating for competition : government, law, and the pharmaceutical industry in the United Kingdom and France
（Government-industry relations, 5）
Clarendon, 1990
Available at / 23 libraries
-
No Libraries matched.
- Remove all filters.
Note
Includes bibliographical references
Description and Table of Contents
Description
The pharmaceutical industry is one of the most closely regualted sectors of the Western economies. In this book, Leigh Hancher analyzes the regulatory systems in France and the UK, with particular emphasis on safety, control of price and profit, and promotional restrictions. She examines in detail the laws on competition and intellectual property as they affect the industry and traces the impact of European law and policy on these different regulatory controls, describing the manner in which national legislators and policy-makers are constrained by EC law. Dr Hancher offers an analysis of regulation as a dynamic process. She explores its impact on the operating environment of major research-based firms and compares the ways in which different legal cultures may provide different opportunities or impose different forms of constraint on policy makers. Her study gives a comprehensive overview of the laws governing competition and intellectual property in France and the UK.
Table of Contents
- The legal context of government-industry relations
- the economics of the pharmaceutical industry
- post-war price control
- evolving patterns of institutionalization
- drug safety and drug marketing
- the impact of European law and policy
- cost control in the 1980's - reappraising health costs in the UK
- cost control and contracts - the French experiment
- regulating pharmaceutical promotion - an impossible task?
- competition law and policy - an alternative strategy?
- regulating for competition - an impossible goal?
by "Nielsen BookData"
